Kineta, Inc. Files 2024 10-K Amendment
| Field | Detail |
|---|---|
| Company | Kineta, Inc./De |
| Form Type | 10-K/A |
| Filed Date | Apr 29, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, 10-K, executive-compensation
TL;DR
Kineta filed its 2024 10-K amendment, check exec comp & equity awards for 2022-2024.
AI Summary
Kineta, Inc./DE filed an amendment to its 2024 10-K on April 29, 2025, reporting on its fiscal year ending December 31, 2024. The company, previously known as Yumanity Therapeutics, Inc. and Proteostasis Therapeutics, Inc., is involved in pharmaceutical preparations. The filing includes details on executive compensation and equity awards for the fiscal years 2022, 2023, and 2024.
Why It Matters
This amendment provides updated financial and operational information for Kineta, Inc. for the fiscal year 2024, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Kineta faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year End (The 10-K/A filing pertains to the fiscal year ending December 31, 2024.)
- 20250429 — Filing Date (This amendment was filed on April 29, 2025.)
Key Players & Entities
- Kineta, Inc./DE (company) — Filer
- Yumanity Therapeutics, Inc. (company) — Former company name
- Proteostasis Therapeutics, Inc. (company) — Former company name
- 20241231 (date) — Fiscal year end
- 20250429 (date) — Filing date
FAQ
What is the primary purpose of this 10-K/A filing for Kineta, Inc./DE?
This filing is an amendment to Kineta, Inc./DE's 10-K for the fiscal year ended December 31, 2024, providing updated information.
What were Kineta, Inc./DE's previous names?
Kineta, Inc./DE was formerly known as Yumanity Therapeutics, Inc. and Proteostasis Therapeutics, Inc.
What is Kineta, Inc./DE's Standard Industrial Classification (SIC) code?
Kineta, Inc./DE's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the business address of Kineta, Inc./DE?
The business address is 7683 SE 27TH STREET, SUITE 481, MERCER ISLAND, WA 98040.
Which fiscal years' executive compensation and equity awards are mentioned in the filing?
The filing references executive compensation and equity awards for the fiscal years 2022, 2023, and 2024.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 29, 2025 regarding KINETA, INC./DE.